CEO and founder of ArrayPatch Ltd. Our mission is to empower healthcare professionals with a superior treatment option, ultimately enhancing patient outcomes. At the core of our mission is the innovative patent microneedle technology, DerMap. Currently, our focus lies in revolutionizing the treatment of nail fungal infections, serving as our initial pathway to market. Our expansive vision includes addressing conditions such as Psoriasis, skin cancer, and Hormone Replacement Therapy in the future.I served as the project leader for Two Enterprise commercialization funds and one European co-fund. I have taken on the responsibility of securing a budget exceeding €1.3M to drive our ambitious initiatives forward. My pivotal role in crafting a comprehensive commercialization strategy for our research outcomes, including the development of a robust business plan and investor materials, has been instrumental in the successful spinout of ArrayPatch Ltd.With over 16 years of experience in designing and executing multidisciplinary research projects within the field of Pharmaceutics, I bring a wealth of expertise to the table. My international experience includes leading and supervising researchers, as well as collaborating with academic and industrial partners. I am passionate about driving innovation and making a lasting impact in the field of healthcare.